从创新到并发症:关于ICI引起的免疫相关结肠炎的病例报告和审查
Huibo Li1,2, Yumiao Pan1,3, Wenzheng Liu4
1Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
免疫检查点抑制剂 (ICI) 可能导致严重的免疫相关结肠炎 (ir- colitis). 早期检测和多学科治疗,包括皮质类固醇,对于有效治疗这种ICI副作用至关重要.
科学领域:
- 癌症学
- 免疫学
- 胃肠病学
背景情况:
- 免疫检查点抑制剂 (ICI) 代表了癌症治疗的突破,但与免疫相关的不良事件 (irAEs) 带来了临床挑战.
- 免疫相关性大肠炎 (ir- colitis) 是一种严重的胃肠炎症,需要及时识别和治疗.
研究的目的:
- 在患有子宫内膜癌的患者中报告因sintilimab (PD- 1抑制剂) 引起的3级结肠炎病例.
- 阐明PD-1阻塞与肠道炎病因之间的机制性联系.
- 在ICI治疗的背景下对肠道结肠炎的管理进行全面的审查.
主要方法:
- 一名68岁的女性患有子宫内膜癌,接受了sintilimab治疗.
- 多学科团队 (MDT) 方法,包括胃肠病学家,瘤学家,病理学家和临床药剂师.
- 对肠道结肠炎诊断和治疗的临床指南进行文献审查和分析.
主要成果:
- 尽管初始治疗,但患者出现严重的急性腹 (三级结肠炎).
- 通过MDT进行高剂量皮质类固醇治疗导致显著的临床改善.
- 这项研究强调了PD-1阻塞在破坏粘膜免疫环境的作用,导致结肠损伤.
结论:
- 早期诊断和干预对于治疗ICI诱导的结肠炎至关重要.
- 一种协作式的MDT方法对于优化患者的治疗结果至关重要.
- 了解肠炎的免疫病原是改善治疗策略和患者教育的关键.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
